Company Valuation: Vector Science and Therapeutics Corp.

Data adjusted to current consolidation scope
Fiscal Period: August 2025
Market Cap 1 0.1109
Change -
Enterprise Value (EV) 1 -2.771
Change -
P/E -0.29x
PBR 0.15x
PEG -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / EBIT 6.06x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 -0.1292
Distribution rate -
Net sales -
EBITDA -
EBIT 1 -0.4571
Net income 1 -0.898
Net Debt 1 -2.882
Reference price 2 0.037
Nbr of stocks (in thousands) 3,000
Announcement Date 4/14/26
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 179M
42.58x7.23x34.91x - 621M
Average 42.58x 7.23x 34.91x 400.34M
Weighted average by Cap. 42.58x 7.23x 34.91x

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PAIN Stock
  4. Valuation Vector Science and Therapeutics Corp.